Clinical Trials Directory

Trials / Completed

CompletedNCT01973192

Viral Pathogenesis of Early Cystic Fibrosis Lung Disease

Status
Completed
Phase
Study type
Observational
Enrollment
65 (actual)
Sponsor
Indiana University School of Medicine · Academic / Other
Sex
All
Age
2 Months – 4 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the hypothesis that early viral infections alter the bacterial flora and inflammatory profile in the airway and accelerate progression of pulmonary disease in infants with cystic fibrosis.

Detailed description

The proposed study is a unique international collaboration between three large CF research centers. This proposal will determine the impact of early respiratory viral infections on bacterial flora and inflammatory profiles in the CF airway as well as the impact of these pathogens on clinical, physiologic and structural markers of disease.The proposed study is designed to follow infants diagnosed with CF through newborn screening to determine the effect of viral infections on the lower airway microbiome, clinical symptoms, pulmonary function and structural changes during the first year of life. The proposed study will measure lower airway inflammation and infection using BAL, oral swabs, and nasal swabs; outcomes will be assessed through infant lung function testing, computerized tomography scans of the chest, and pulmonary exacerbation rate.

Conditions

Timeline

Start date
2013-05-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2013-10-31
Last updated
2017-04-04

Locations

4 sites across 2 countries: United States, Australia

Source: ClinicalTrials.gov record NCT01973192. Inclusion in this directory is not an endorsement.